BATSR: BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence
-
Enrollment
This study is not currently enrolling. -
Associated Conditions
-
Research Area
Translational Research -
Principal Investigator
-
Sponsor
AdventHealth CFD
To be enrolled in this study, you must meet certain requirements. You may be eligible to participate if you meet the following criteria:
BMI ≤35 kg/m2
65-90 years of age
Study Duration: Up to 120 days
Study Commitment:
1 Screening visit
1 Overnight visits
3 Outpatient visits
Study Procedures:
Medical History review, Physical exams, EKG’s (electrocardiogram)
Bloodwork, urinalysis
Body Weight, Height, Waist measurements
MRI’s & DXA’s
Exercise training
Questionnaires
Glucose Clamp with RMR
Compensation offered up to $500 (athlete group)
This study is being conducted under the direction of Paul Coen, PhD at 301 East Princeton Street, Orlando, Florida 32804.